Chinese Orthopedic Biomaterials Market
The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.
The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for China.
Others Include: Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for China.
Others Include: Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 PROCEDURES
1.4 BONE GRAFT SUBSTITUTE MARKET
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.6 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
CHINESE ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.7.2 Market Concentration
3.8MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2MARKET OVERVIEW
4.3MARKET ANALYSIS & FORECAST
4.3.1 Allograft Market
4.3.1.1 Total Allograft Market
4.3.2 Synthetic Market
4.3.2.1 Total Synthetic Market
4.3.3 Demineralized Bone Matrix Market
4.3.3.1 Total DBM Market
4.3.4 Market by Indication
4.3.5 Cervical Market
4.3.6 Thoracolumbar Market
4.3.7 Trauma & Reconstruction Market
4.3.8 Craniomaxillofacial Market
4.3.8.1 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2MARKET OVERVIEW
5.3MARKET ANALYSIS & FORECAST
5.3.1 Single Injection Market
5.3.2 Three Injection Cycle Market
5.3.3 Five Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
APPENDIX: (OPTIONAL)
ABBREVIATIONS
1.1 CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 PROCEDURES
1.4 BONE GRAFT SUBSTITUTE MARKET
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.6 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
CHINESE ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.7.2 Market Concentration
3.8MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2MARKET OVERVIEW
4.3MARKET ANALYSIS & FORECAST
4.3.1 Allograft Market
4.3.1.1 Total Allograft Market
4.3.2 Synthetic Market
4.3.2.1 Total Synthetic Market
4.3.3 Demineralized Bone Matrix Market
4.3.3.1 Total DBM Market
4.3.4 Market by Indication
4.3.5 Cervical Market
4.3.6 Thoracolumbar Market
4.3.7 Trauma & Reconstruction Market
4.3.8 Craniomaxillofacial Market
4.3.8.1 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2MARKET OVERVIEW
5.3MARKET ANALYSIS & FORECAST
5.3.1 Single Injection Market
5.3.2 Three Injection Cycle Market
5.3.3 Five Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
APPENDIX: (OPTIONAL)
ABBREVIATIONS
